Blog
RSS FeedPosted by Michael Wonder on 22 Jun 2020
PMPRB publishes new draft guidelines, launches 30 day consultation
22 June 2020 - As reported earlier this month, the Patented Medicine Prices Review Board has published a new draft ...
Posted by Michael Wonder on 22 Jun 2020
‘Pfizer’s Vyndaqel, Vyndamax do not deserve rare disease pricing’
22 June 2020 - Pfizer’s Vyndaqel and Vyndamax -- containing tafamidis to treat cardiomyopathy caused by transthyretin amyloidosis (ATTR-CM) -- do ...
Posted by Michael Wonder on 20 Jun 2020
ICER to assess whether the most significant prescription drug price increases are supported by new clinical evidence
19 June 2020 - Public input on drugs of concern will be accepted through 17 July 2020. ...
Posted by Michael Wonder on 18 Jun 2020
Trump administration seeks to encourage ‘value-based’ drug pricing deals with new proposal
17 June 2020 - The Trump administration wants to revamp certain Medicaid rules about drug prices in hopes of encouraging ...
Posted by Michael Wonder on 18 Jun 2020
US court nixes drug maker price disclosure
18 June 2020 - A US court has ruled against a move by President Donald Trump's administration to try to bring ...
Posted by Michael Wonder on 16 Jun 2020
Supreme Court will not hear generic drug price fixing discovery dispute
16 June 2020 - The U.S. Supreme Court on Monday declined to hear generic drug makers’ challenge to a court ...
Posted by Michael Wonder on 15 Jun 2020
The unprecedented challenge of pricing a coronavirus vaccine
12 June 2020 - The optimal pricing strategy for a new vaccine involves setting a fair and sustainable price that ...
Posted by Michael Wonder on 10 Jun 2020
Coalition of attorneys general file third lawsuit against generic drug ‘price-fixing’
10 June 2020 - New York Attorney General Letitia James announced on 10 June, that she and a coalition of 51 ...
Posted by Michael Wonder on 10 Jun 2020
Price limits will scare off COVID-19 vaccine makers, Fauci warns
10 June 2020 - More than one vaccine will be needed, Fauci says. ...
Posted by Michael Wonder on 09 Jun 2020
The coronavirus pandemic is reigniting a fierce debate over compounded drugs
9 June 2020 - In hopes of alleviating potential drug shortages and other issues wrought by the coronavirus pandemic, the ...
Posted by Michael Wonder on 08 Jun 2020
Fate of pharma’s reputation lies in Gilead’s hands on pricing of COVID-19 drug remdesivir
8 June 2020 - Few remember the time when the pharmaceutical industry was the world’s most admired. ...
Posted by Michael Wonder on 04 Jun 2020
Wholesale drug prices — and net prices — keep falling for most drugs
4 June 2020 - A mid continued political pressure on the pharmaceutical industry, a new analysis finds that brand-name drug ...
Posted by Michael Wonder on 03 Jun 2020
Lower prices and greater patient access — lessons from Germany’s drug purchasing structure
3 June 2020 - The German system for determining drug prices features collective negotiations on the part of competing health plans. ...
Posted by Michael Wonder on 03 Jun 2020
How a US-UK trade agreement could affect NHS drug prices
1 June 2020 - The governments of the UK and US are working on the outlines of a trade agreement. ...
Posted by Michael Wonder on 01 Jun 2020
Canada's new drug price rules pushed to next year
1 June 2020 - Canada's drug pricing agency said on Monday that new regulations aimed at lowering costs would come ...